These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23672513)

  • 21. Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy.
    Wu SG; Li Q; Zhou J; Sun JY; Li FY; Lin Q; Lin HX; Gaun XX; He ZY
    Cancer Res Treat; 2015 Oct; 47(4):757-64. PubMed ID: 25672578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node ratio should be considered for incorporation into staging for breast cancer.
    Chagpar AB; Camp RL; Rimm DL
    Ann Surg Oncol; 2011 Oct; 18(11):3143-8. PubMed ID: 21847696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study.
    Mansouri H; Zemni I; Sakhri S; Ayadi MA; Boujelbene N; Ben Dhiab T
    Womens Health (Lond); 2024; 20():17455057241285396. PubMed ID: 39340307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
    Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
    J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
    van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
    Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.
    Wang F; He W; Qiu H; Wang X; Guo G; Chen X; Rong Y; Zhou F; Yin C; Yuan Z; Xia L
    Clin Breast Cancer; 2012 Dec; 12(6):404-11. PubMed ID: 23026023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up.
    Danko ME; Bennett KM; Zhai J; Marks JR; Olson JA
    J Am Coll Surg; 2010 May; 210(5):797-805.e1, 805-7. PubMed ID: 20421053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer.
    Truong PT; Vinh-Hung V; Cserni G; Woodward WA; Tai P; Vlastos G;
    Eur J Cancer; 2008 Aug; 44(12):1670-7. PubMed ID: 18595686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma.
    Deberti M; Goupille C; Arbion F; Vilde A; Body G; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2023 Dec; 52(10):102665. PubMed ID: 37734568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymph node ratio: a new feature for defining risk category of node-positive breast cancer patients.
    Yang C; Liu F; Li S; Li W; Zhai L; Ren M; Li Y; Lang R; Fan Y; Zhang X; Fu L
    Int J Surg Pathol; 2012 Dec; 20(6):546-54. PubMed ID: 22736300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node ratio as an alternative to pN staging in node-positive breast cancer.
    Vinh-Hung V; Verkooijen HM; Fioretta G; Neyroud-Caspar I; Rapiti E; Vlastos G; Deglise C; Usel M; Lutz JM; Bouchardy C
    J Clin Oncol; 2009 Mar; 27(7):1062-8. PubMed ID: 19164210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node ratio as an alternative to pN staging for predicting prognosis after neoadjuvant chemotherapy in breast cancer.
    Cho DH; Bae SY; You JY; Kim HK; Chang YW; Choi YJ; Woo SU; Son GS; Lee JB; Bae JW; Jung SP
    Kaohsiung J Med Sci; 2018 Jun; 34(6):341-347. PubMed ID: 29747778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additional Prognostic Value of Lymph Node Ratio (LNR) and Number of Negative Lymph Nodes (NLNs) in Chinese Patients with Triple Negative Breast Cancer.
    Wang QX; Cai YF; Chen YY; Zhang W; Jin WX; Chen ED; Zhang XH; Li Q
    Ann Clin Lab Sci; 2017 Jan; 47(1):68-75. PubMed ID: 28249920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy.
    Jian-Hui C; Shi-Rong C; Hui W; Si-le C; Jian-Bo X; Er-Tao Z; Chuang-Qi C; Yu-Long H
    Tumour Biol; 2016 Aug; 37(8):11105-13. PubMed ID: 26912060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes.
    Shirai Y; Sakata J; Wakai T; Ohashi T; Ajioka Y; Hatakeyama K
    World J Surg Oncol; 2012 May; 10():87. PubMed ID: 22594526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients.
    Schiffman SC; McMasters KM; Scoggins CR; Martin RC; Chagpar AB
    J Am Coll Surg; 2011 Jul; 213(1):45-52; discussion 52-3. PubMed ID: 21601490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.